GTC Biotherapeutics Inc., of Framingham, say it's acquired an exclusive license to develop three recombinant human proteins from ProGenetics LLC of Blacksburg, Va.
GTC has been pioneering the production of therapeutic human proteins from the milk of animals.
From the GTC website:
The key enabling science for GTC Biotherapeutics (GTC) is the development of human therapeutic proteins in the milk of transgenic animals. Transgenic animals carry genetic information allowing them to express these human therapeutic proteins in their milk. Once they are produced, these recombinant proteins can be efficiently purified from milk for use as therapeutics.
The company press release is here.
A quick aside: A short blurb in from bizjournals is here. The sentence that caught my eye is this:
With 143 workers, GTC reported a 2006 net loss of $35.3 million on revenue of $6.1 million.
Ain't capitalism grand. The sheer optimism necessary to make ventures like this work. And in the end it make not work.
Non-injectable Factor?...
Not yet, but some initial steps.
Nastech Pharmaceutical Company Inc. of Bothell, Wa has entered into a feasibility study with an undisclosed global leader in the production of plasma products to develop a non-injectable Factor IX product.
Who is the "undisclosed global leader in the production of plasma products"? We could certainly make some well-informed guesses. But really, don't know, don't care. Do it and get it done.
No comments:
Post a Comment